Pharmacokinetics and Glucodynamics of LY900014 Compared to Insulin Lispro Following Single Dose Administration in Elderly and Younger Adults With Type 1 Diabetes Mellitus
Phase of Trial: Phase I
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 15 Aug 2017 Planned number of patients changed from 72 to 84.
- 09 Jun 2017 Status changed from not yet recruiting to recruiting.
- 26 May 2017 New trial record